Newer anticonvulsants: Dosing strategies and cognition in treating patients with mood disorders and epilepsy

Journal of Clinical Psychiatry

Volumn 64, Issue SUPPL. 8, 2003, Pages 30-34

  Meador, Kimford J ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; DONNATAL; ETIRACETAM; FELBAMATE; GABAPENTIN; LAMOTRIGINE; OXCARBAZEPINE; PHENYTOIN; PLACEBO; TIAGABINE; TOPIRAMATE; VALPROIC ACID; ZONISAMIDE;

ADULT; AGITATION; ANTICONVULSANT THERAPY; ARTICLE; BIPOLAR DISORDER; BONE MARROW TOXICITY; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; EPILEPSY; HUMAN; HYPERACTIVITY; IRRITABILITY; LIVER TOXICITY; MENTAL DISEASE; MULTICENTER STUDY; NEUROTOXICITY; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; SEIZURE; SINGLE BLIND PROCEDURE; TREATMENT OUTCOME;

ANTICONVULSANTS; ANTIMANIC AGENTS; BIPOLAR DISORDER; CLINICAL TRIALS; COGNITION DISORDERS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; EPILEPSY; HUMANS;

EID: 0041866161     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Lyons AS, Petrucelli RJ. Medicine: An Illustrated History. New York, NY: Harry N Abrahms, Inc; 1987:376-377
2. Bender GA, Thom RA. Pictorial Annals of Medicine and Pharmacy. Morris Plains, NJ: Warner-Lambert Co; 1999:52-55
3. Meador KJ. Cognitive effects of epilepsy and of antiepileptic medications. In: Wyllie E, ed. The Treatment of Epilepsy: Principles and Practice. 3rd ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2001:1215-1225
4. Meador KJ. Cognitive and behavioral assessments in antiepileptic drug trials. In: French J, Dichter M, Leppik I, eds. Antiepileptic Drug Development, Advances in Neurology Series, vol 76. Philadelphia, Pa: Lippincott-Raven; 1998;231-238
5. Perrine K, Hermann BP, Meador KJ, et al. The relationship of neuropsychological functioning to quality of life in epilepsy. Arch Neurol 1995;52:997-1003
6. Meador KJ, Loring DW, Allen ME, et al. Comparative cognitive effects of carbamazepine and phenytoin in healthy adults. Neurology 1991;41:1537-1540
7. Meador KJ, Loring DW, Abney OL, et al. Effects of carbamazepine and phenytoin on EEG and memory in healthy adults. Epilepsia 1993;34:153-157
8. Meador KJ, Loring DW, Moore EE, et al. Comparative cognitive effects of phenobarbital, phenytoin, and valproate in healthy adults. Neurology 1995;45:1494-1499
9. Meador KJ, Loring DW, Thompson EE, et al. Differential cognitive effects of terfenadine and chlorpheniramine. J Allergy Clin Immunol 1989;84:322-325
10. Dimond KR, Pande AC, Lamoreaux L, et al. Effect of gabapentin (Neurontin) on mood and well-being in patients with epilepsy. Prog Neuropsychopharmacol Biol Psychiatry 1996;20:407-417
11. Dodrill CB, Arnett JL, Hayes AG, et al. Cognitive abilities and adjustment with gabapentin: results of a multisite study. Epilepsy Res 1999;35:109-121
12. Harden CL, Lazar LM, Pick LH, et al. A beneficial effect on mood in partial epilepsy patients treated with gabapentin. Epilepsia 1999;40:1129-1134
13. Lee DO, Steingard RJ, Cesena M, et al. Behavioral side effects of gabapentin in children. Epilepsia 1996;37:87-90
14. Wolf SM, Shinnar S, Kang H, et al. Gabapentin toxicity in children manifesting as behavioral changes. Epilepsia 1995;36:1203-1205
15. Leach JP, Girvan J, Paul A, et al. Gabapentin and cognition: a double blind, dose ranging, placebo controlled study in refractory epilepsy. J Neurol Neurosurg Psychiatry 1997;62:372-376
16. Meador KJ, Lofing DW, Ray PG, et al., Differential cognitive effects of carbamazepine and gabapentin. Epilepsia 1999;40:1279-1285
17. Smith D, Baker G, Davies G, et al. Outcomes of add-on treatment with lamotrigine in partial epilepsy. Epilepsia 1993;34:312-322
18. Gillham R, Baker G, Thompson P, et al. Standardisation of a self-report questionnaire for use in evaluating cognitive, affective and behavioural side-effects of anti-epileptic drug treatments. Epilepsy Res 1996;24:47-55
19. Steiner TJ, Dellaportas CI, Findley LJ, et al. Lamotrigine monotherapy in newly diagnosed untreated epilepsy: a double-blind comparison with phenytoin. Epilepsia 1999;40:601-607
20. Meador KJ, Loring DW, Ray PG, et al. Differential cognitive and behavioral effects of carbamazepine and lamotrigine. Neurology 2001;56:1177-1182
21. Aikia M, Kalviainen R, Sivenius J, et al. Cognitive effects of oxcarbazepine and phenytoin monotherapy in newly diagnosed epilepsy: one year follow-up. Epilepsy Res 1992;11:199-203
22. Curran HV, Java R. Memory and psychomotor effects of oxcarbazepine in healthy human volunteers. Eur J Clin Pharmacol 1993;44:529-533
23. Dodrill CB, Arnett JL, Sommerville KW, et al. Cognitive and quality of life effects of differing dosages of tiagabine in epilepsy. Neurology 1997;48:1025-1031
24. Dodrill CB, Arnett JL, Deaton R, et al. Tiagabine versus phenytoin and carbamazepine as add-on therapies: effects on abilities, adjustment, and mood. Epilepsy Res 2000;42:123-132
25. Meador KJ, Kamin M. Assessing cognitive effects of a new AED without bias of practice effects [abstract]. Epilepsia 1997;38(suppl 3):60
26. Martin R, Kuzniecky R, Ho S, et al. Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults. Neurology 1999;52:321-327
27. Thompson PJ, Baxendale SA, Duncan JS, et al. Effects of topiramate on cognitive function. J Neurol Neurosurg Psychiatry 2000;69:636-641
28. Aldenkamp AP, Baker G, Mulder OG, et al. A multicenter, randomized clinical study to evaluate the effect on cognitive function of topiramate compared with valproate as add-on therapy to carbamazepine in patients with partial-onset seizures. Epilepsia 2000;41:1167-1178
29. Meador KJ, Hulihan J, Karim R. Cognitive function in adults with epilepsy: effect of topiramate and valproate added to carbamazepine [abstract]. Epilepsia 2001;42(suppl 2):75
30. Berent S, Sackellares JC, Giordani B, et al. Zonisamide (CI-912) and cognition: results from preliminary study. Epilepsia 1987;28:61-67